Table of Content

1. Product Overview
1.1. Indication
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4.1 Dosage Forms and Strengths
1.4. Route of Synthesis
1.5. Pharmacology
1.4.2 Pharmacodynamics
1.4.3 Pharmacokinetics
1.6. Adverse Reactions
1.7. Product Snapshot
1.8. Development Milestones of Enhertu
1.9. Marketed Details
1.4.4 United States
1.4.5 Europe
1.4.6 Japan
1.10. Patent Details

2. SWOT Analysis
2.1. Analyst Views

3. Regulatory Milestones
3.1. Approvals
3.2. Research and Development
3.3. Clinical Trials Information
3.4. Safety and Efficacy
3.5. Product Developmental Activities

4. Market Assessment
4.1. 7MM Market Analysis
4.2. United States
4.3. Europe
4.4. Japan
4.5. Key Findings

5. Market Competitors

6. Emerging Therapies

7. Appendix
7.1. Report Purchase Options



List of Figures


Figure 1 The Development Timeline of Enhertu
Figure 2 Patent Details, Enhertu
Figure 3 Enhertu, 7MM Market Size from 2017 to 2030 (in Million USD)
Figure 4 Enhertu, US Market Size from 2017 to 2030 (in Millions USD)
Figure 5 Enhertu, EU Market Size from 2017 to 2030 (in Millions USD)
Figure 6 Enhertu, EU5 Market Size from 2017 to 2030 (in Millions USD)
Figure 7 Enhertu, Japan Market Size from 2017 to 2030 (in Millions USD)


List of Tables


Table 1 Enhertu, Description
Table 2 Enhertu, Trial Diversification
Table 3 Enhertu, Marketed Details United States
Table 4 Enhertu, Marketed Details Europe
Table 5 Enhertu, Marketed Details Japan
Table 6 Patent Details: Enhertu
Table 7 Enhertu, Clinical Trial Description, 2020
Table 8 Safety and Efficacy Results for Enhertu
Table 9 Enhertu, 7MM Market Size from 2017 to 2030 (in Million USD)
Table 10 Enhertu, US Market Size from 2017 to 2030 (in Million USD)
Table 11 Enhertu, EU Market Size from 2017 to 2030 (in Million USD)
Table 12 Enhertu, EU5 Market Size from 2017 to 2030 (in Millions USD)
Table 13 Enhertu, Japan Market Size from 2017 to 2030 (in Million USD)
Table 14 Market Competitors
Table 15 Emerging Therapies